These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 12695018)
41. Freeze drying of double emulsions to prepare topotecan-entrapping liposomes featuring controlled release. Wang T; Wang N; Li T; Deng Y Drug Dev Ind Pharm; 2008 Apr; 34(4):427-33. PubMed ID: 18401785 [TBL] [Abstract][Full Text] [Related]
42. 5-Fluorouracil encapsulated alginate beads for the treatment of breast cancer. Arica B; Caliş S; Kaş H; Sargon M; Hincal A Int J Pharm; 2002 Aug; 242(1-2):267-9. PubMed ID: 12176261 [TBL] [Abstract][Full Text] [Related]
43. Ethanol-based proliposome delivery systems of paclitaxel for in vitro application against brain cancer cells. Najlah M; Jain M; Wan KW; Ahmed W; Albed Alhnan M; Phoenix DA; Taylor KMG; Elhissi A J Liposome Res; 2018 Mar; 28(1):74-85. PubMed ID: 27834116 [TBL] [Abstract][Full Text] [Related]
44. Ethogel topical formulation for increasing the local bioavailability of 5-fluorouracil: a mechanistic study. Puri R; Jain S Anticancer Drugs; 2012 Oct; 23(9):923-34. PubMed ID: 22926258 [TBL] [Abstract][Full Text] [Related]
45. Encapsulation and stability of clofazimine liposomes. Patel VB; Misra AN J Microencapsul; 1999; 16(3):357-67. PubMed ID: 10340220 [TBL] [Abstract][Full Text] [Related]
46. RETRACTED: Enhanced antitumor efficacy of 5-fluorouracil loaded methoxy poly(ethylene glycol)-poly(lactide) nanoparticles for efficient therapy against breast cancer. Yuan Z; Qu X; Wang Y; Zhang DY; Luo JC; Jia N; Zhang ZT Colloids Surf B Biointerfaces; 2015 Apr; 128():489-497. PubMed ID: 25779606 [TBL] [Abstract][Full Text] [Related]
47. Modulated release of 5-fluorouracil from pH-sensitive and colon targeted pellets: an industrially feasible approach. Kulthe SS; Bahekar JK; Godhani CC; Choudhari YM; Inamdar NN; Mourya VK Drug Dev Ind Pharm; 2013 Jan; 39(1):138-45. PubMed ID: 22369145 [TBL] [Abstract][Full Text] [Related]
48. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. Mokhtar M; Sammour OA; Hammad MA; Megrab NA Int J Pharm; 2008 Sep; 361(1-2):104-11. PubMed ID: 18577437 [TBL] [Abstract][Full Text] [Related]
49. Encapsulation efficiency and controlled release characteristics of crosslinked polyacrylamide particles. Sairam M; Babu VR; Vijaya B; Naidu K; Aminabhavi TM Int J Pharm; 2006 Aug; 320(1-2):131-6. PubMed ID: 16766148 [TBL] [Abstract][Full Text] [Related]
50. Niosomes as carriers for tretinoin. I. Preparation and properties. Manconi M; Sinico C; Valenti D; Loy G; Fadda AM Int J Pharm; 2002 Mar; 234(1-2):237-48. PubMed ID: 11839454 [TBL] [Abstract][Full Text] [Related]
51. Layer-by-layer assembly of poly(L-glutamic acid)/chitosan microcapsules for high loading and sustained release of 5-fluorouracil. Yan S; Zhu J; Wang Z; Yin J; Zheng Y; Chen X Eur J Pharm Biopharm; 2011 Aug; 78(3):336-45. PubMed ID: 21195174 [TBL] [Abstract][Full Text] [Related]
52. In vitro release of hydrophilic and hydrophobic drugs from liposomal dispersions and gels. Nounou MM; El-Khordagui LK; Khalafallah NA; Khalil SA Acta Pharm; 2006 Sep; 56(3):311-24. PubMed ID: 19831280 [TBL] [Abstract][Full Text] [Related]
53. Poly(styrene-co-maleic acid)-based pH-sensitive liposomes mediate cytosolic delivery of drugs for enhanced cancer chemotherapy. Banerjee S; Sen K; Pal TK; Guha SK Int J Pharm; 2012 Oct; 436(1-2):786-97. PubMed ID: 22884831 [TBL] [Abstract][Full Text] [Related]
54. A targeted liposome delivery system for combretastatin A4: formulation optimization through drug loading and in vitro release studies. Nallamothu R; Wood GC; Kiani MF; Moore BM; Horton FP; Thoma LA PDA J Pharm Sci Technol; 2006; 60(3):144-55. PubMed ID: 17089683 [TBL] [Abstract][Full Text] [Related]
55. The role of surfactants in the formulation of elastic liposomal gels containing a synthetic opioid analgesic. Singh S; Vardhan H; Kotla NG; Maddiboyina B; Sharma D; Webster TJ Int J Nanomedicine; 2016; 11():1475-82. PubMed ID: 27114707 [TBL] [Abstract][Full Text] [Related]
56. Study of azathioprine encapsulation into liposomes. Gulati M; Grover M; Singh M; Singh S J Microencapsul; 1998; 15(4):485-94. PubMed ID: 9651870 [TBL] [Abstract][Full Text] [Related]
57. The Impact of Liposomal Formulations on the Release and Brain Delivery of Methotrexate: An In Vivo Microdialysis Study. Hu Y; Rip J; Gaillard PJ; de Lange ECM; Hammarlund-Udenaes M J Pharm Sci; 2017 Sep; 106(9):2606-2613. PubMed ID: 28322936 [TBL] [Abstract][Full Text] [Related]
58. The encapsulation of idarubicin within liposomes using the novel EDTA ion gradient method ensures improved drug retention in vitro and in vivo. Gubernator J; Chwastek G; Korycińska M; Stasiuk M; Grynkiewicz G; Lewrick F; Süss R; Kozubek A J Control Release; 2010 Aug; 146(1):68-75. PubMed ID: 20510316 [TBL] [Abstract][Full Text] [Related]
59. Development and characterization of dutasteride bearing liposomal systems for topical use. Sharma P; Jain D; Maithani M; Mishra SK; Khare P; Jain V; Singh R Curr Drug Discov Technol; 2011 Jun; 8(2):136-45. PubMed ID: 21513483 [TBL] [Abstract][Full Text] [Related]
60. PEGylated Liposomes of Meloxicam: Optimization by Quality by Design, in vitro Characterization and Cytotoxicity Evaluation. Shaji J; Menon I Pharm Nanotechnol; 2017; 5(2):119-137. PubMed ID: 28462699 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]